These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 9710526)

  • 21. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
    Moroz IA; Peciña S; Schallert T; Stewart J
    Exp Neurol; 2004 Sep; 189(1):78-93. PubMed ID: 15296838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
    Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
    Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease.
    Metz GA; Piecharka DM; Kleim JA; Whishaw IQ
    Brain Res; 2004 Nov; 1026(1):126-35. PubMed ID: 15476704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat.
    Lee CS; Sauer H; Bjorklund A
    Neuroscience; 1996 Jun; 72(3):641-53. PubMed ID: 9157311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
    Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A
    Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
    Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
    J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions.
    Quesada A; Micevych PE
    J Neurosci Res; 2004 Jan; 75(1):107-16. PubMed ID: 14689453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lesioning of the striatum reverses motor asymmetry in the 6-hydroxydopamine rodent model of parkinsonism.
    Friehs GM; Parker RG; He LS; Haines SJ; Turner DA; Ebner TJ
    J Neural Transplant Plast; 1991; 2(2):141-56. PubMed ID: 1684115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transsynaptic effect of an intrastriatal fetal nigral graft on the sensitivity of the substantia nigra pars reticulata to muscimol in the rat.
    Gaudin DP; St-Pierre JA; Lavoie B; Bédard PJ
    Exp Neurol; 1994 May; 127(1):45-53. PubMed ID: 8200436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioral characterization.
    Thomas J; Wang J; Takubo H; Sheng J; de Jesus S; Bankiewicz KS
    Exp Neurol; 1994 Apr; 126(2):159-67. PubMed ID: 7925817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral and subthalamic effects of combining a fetal ventral mesencephalic transplant in striatum with an electrolytic lesion of the entopeduncular nucleus in the rat with a unilateral 6-OHDA lesion of substantia nigra.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 2003 May; 48(2):90-9. PubMed ID: 12619043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway.
    Annett LE; Martel FL; Rogers DC; Ridley RM; Baker HF; Dunnett SB
    Exp Neurol; 1994 Feb; 125(2):228-46. PubMed ID: 7906227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's disease.
    Tsuboi K; Shults CW
    Exp Neurol; 2002 Jan; 173(1):95-104. PubMed ID: 11771942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
    Iancu R; Mohapel P; Brundin P; Paul G
    Behav Brain Res; 2005 Jul; 162(1):1-10. PubMed ID: 15922062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: role of the intranigral graft.
    Baker KA; Sadi D; Hong M; Mendez I
    J Comp Neurol; 2000 Oct; 426(1):106-16. PubMed ID: 10980486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. II. Transplant-induced behavioral recovery.
    Nikkhah G; Cunningham MG; McKay R; Björklund A
    J Neurosci; 1995 May; 15(5 Pt 1):3562-70. PubMed ID: 7751930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools.
    Gomide V; Bibancos T; Chadi G
    Int J Neurosci; 2005 Apr; 115(4):557-82. PubMed ID: 15804725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of recovery in the hemiparkinson rat: drug-induced rotation is inadequate.
    Castañeda E; Fleming S; Paquette MA; Boat K; Moffett J; Stachowiak EK; Bloom DC; Stachowiak MK
    Physiol Behav; 2005 Mar; 84(4):525-35. PubMed ID: 15811387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.